pubmed-article:14648020 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14648020 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
pubmed-article:14648020 | lifeskim:mentions | umls-concept:C0259898 | lld:lifeskim |
pubmed-article:14648020 | lifeskim:mentions | umls-concept:C0002679 | lld:lifeskim |
pubmed-article:14648020 | lifeskim:mentions | umls-concept:C0009429 | lld:lifeskim |
pubmed-article:14648020 | lifeskim:mentions | umls-concept:C0076110 | lld:lifeskim |
pubmed-article:14648020 | lifeskim:mentions | umls-concept:C0205221 | lld:lifeskim |
pubmed-article:14648020 | lifeskim:mentions | umls-concept:C0556895 | lld:lifeskim |
pubmed-article:14648020 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:14648020 | pubmed:dateCreated | 2004-5-12 | lld:pubmed |
pubmed-article:14648020 | pubmed:abstractText | A case of disseminated infection with Fusarium oxysporum following chemotherapy of acute myelogenous leukemia is reported. Antifungal treatment was successful with a 13-day course of oral terbinafine 250 mg t.i.d. in combination with amphotericin B deoxycholate 1.0-1.5 mg/kg qd and subsequently intravenous liposomal amphotericin B 5 mg/kg qd. Preceding monotherapy with amphotericin B deoxycholate 1.0-1.5 mg/kg qd had not stopped the progression of infection. The combination therapy described here represents a novel approach to the treatment of Fusarium spp. in the immunocompromised host in whom Fusarium spp. are known to cause disseminated infection with high mortality. | lld:pubmed |
pubmed-article:14648020 | pubmed:language | eng | lld:pubmed |
pubmed-article:14648020 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14648020 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14648020 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14648020 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14648020 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14648020 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14648020 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14648020 | pubmed:month | Jun | lld:pubmed |
pubmed-article:14648020 | pubmed:issn | 0939-5555 | lld:pubmed |
pubmed-article:14648020 | pubmed:author | pubmed-author:RotheAA | lld:pubmed |
pubmed-article:14648020 | pubmed:author | pubmed-author:EngertAA | lld:pubmed |
pubmed-article:14648020 | pubmed:author | pubmed-author:SeifertHH | lld:pubmed |
pubmed-article:14648020 | pubmed:author | pubmed-author:CasparCC | lld:pubmed |
pubmed-article:14648020 | pubmed:author | pubmed-author:FätkenheuerGG | lld:pubmed |
pubmed-article:14648020 | pubmed:author | pubmed-author:SeiboldMM | lld:pubmed |
pubmed-article:14648020 | pubmed:author | pubmed-author:TintelnotKK | lld:pubmed |
pubmed-article:14648020 | pubmed:author | pubmed-author:KarthausMM | lld:pubmed |
pubmed-article:14648020 | pubmed:author | pubmed-author:CornelyO AOA | lld:pubmed |
pubmed-article:14648020 | pubmed:author | pubmed-author:BetheUU | lld:pubmed |
pubmed-article:14648020 | pubmed:author | pubmed-author:HoppeThT | lld:pubmed |
pubmed-article:14648020 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14648020 | pubmed:volume | 83 | lld:pubmed |
pubmed-article:14648020 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14648020 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14648020 | pubmed:pagination | 394-7 | lld:pubmed |
pubmed-article:14648020 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:meshHeading | pubmed-meshheading:14648020... | lld:pubmed |
pubmed-article:14648020 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:14648020 | pubmed:articleTitle | Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. | lld:pubmed |
pubmed-article:14648020 | pubmed:affiliation | Klinik I für Innere Medizin, Universität zu Köln, Joseph-Stelzmann-Str. 9, 50931 Cologne, Germany. | lld:pubmed |
pubmed-article:14648020 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14648020 | pubmed:publicationType | Case Reports | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14648020 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14648020 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14648020 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14648020 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14648020 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14648020 | lld:pubmed |